# LYSMD4

## Overview
LYSMD4 is a gene that encodes the protein LysM domain containing 4, which is characterized by the presence of a LysM domain, typically involved in binding peptidoglycans. This protein is implicated in various biological processes, including bone metabolism and immune response. It interacts with the insulin-like growth factor 1 receptor (IGF1R), suggesting a role in osteoblast differentiation and bone formation, and is involved in pathways that influence bone resorption and inflammatory cytokine production. Additionally, LYSMD4 has been associated with neurological conditions such as schizophrenia, where it is overexpressed in certain brain regions, indicating a potential role in brain morphology and function. The gene's involvement in Alzheimer's Disease and bone mineral density further underscores its significance in both neurological and metabolic health (Greenbaum2021A; Mews2024Brain; Morgan2019Cortical).

## Clinical Significance
LYSMD4 has been implicated in several diseases through alterations in its expression levels and genetic associations. In the context of psychosis and schizophrenia, LYSMD4 is overexpressed in brain regions where morphometric similarity is increased in patients, suggesting a link between its expression and anatomical brain differences associated with these conditions (Morgan2019Cortical). However, there is no significant enrichment of LYSMD4 for common sequence variants associated with schizophrenia from recent genome-wide association studies (GWAS) (Morgan2019Cortical).

In Alzheimer's Disease (AD), LYSMD4 was identified as one of the novel genes associated with the condition through transcriptome-wide association studies (TWAS). Although initially significant in brain cortex associations, its significance diminished when a sparse genetic model was applied, indicating a potential polygenic influence (Mews2024Brain).

LYSMD4 has also been associated with bone mineral density (BMD) in a multiethnic whole genome sequencing study. It was identified in male-specific genetic associations with BMD, suggesting a role in bone metabolism, possibly through its interaction with inflammatory pathways and IGF-1 signaling, which are crucial for bone formation (Greenbaum2021A).

## Interactions
LYSMD4 (LysM domain containing 4) is involved in several interactions that suggest its role in bone health and immune response. In the context of bone mineral density, LYSMD4 has been identified as a low-frequency variant with a large effect size in males. It interacts with the insulin-like growth factor 1 receptor (IGF1R), which is crucial for osteoblast differentiation and bone formation. This interaction indicates a potential role for LYSMD4 in bone health through its involvement in IGF-1 signaling pathways (Greenbaum2021A).

LYSMD4 is also implicated in immune response pathways. It is noted for its role in influencing peptidoglycan binding, which can induce bone resorption by stimulating toll-like receptor and nucleotide-binding oligomerization domain signaling pathways, leading to the production of inflammatory cytokines (Greenbaum2021A). 

In the context of psychosis, particularly schizophrenia, LYSMD4 is overexpressed in regions with increased morphometric similarity in patients. It is strongly positively weighted on PLS1, correlating with case-control differences in regional morphometric similarity, suggesting its involvement in brain expression patterns associated with schizophrenia (Morgan2019Cortical). 

These interactions highlight LYSMD4's multifaceted role in both bone metabolism and neurological conditions.


## References


[1. (Greenbaum2021A) Jonathan Greenbaum, Kuan-Jui Su, Xiao Zhang, Yong Liu, Anqi Liu, Lan-Juan Zhao, Zhe Luo, Qing Tian, Hui Shen, and Hong-Wen Deng. A multiethnic whole genome sequencing study to identify novel loci for bone mineral density. Human Molecular Genetics, 31(7):1067–1081, October 2021. URL: http://dx.doi.org/10.1093/hmg/ddab305, doi:10.1093/hmg/ddab305. This article has 13 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1093/hmg/ddab305)

2. (Mews2024Brain) Brain and Blood Transcriptome-Wide Association Studies Identify Five Novel Genes Associated with Alzheimer’s Disease. This article has 0 citations.

[3. (Morgan2019Cortical) Sarah E. Morgan, Jakob Seidlitz, Kirstie J. Whitaker, Rafael Romero-Garcia, Nicholas E. Clifton, Cristina Scarpazza, Therese van Amelsvoort, Machteld Marcelis, Jim van Os, Gary Donohoe, David Mothersill, Aiden Corvin, Andrew Pocklington, Armin Raznahan, Philip McGuire, Petra E. Vértes, and Edward T. Bullmore. Cortical patterning of abnormal morphometric similarity in psychosis is associated with brain expression of schizophrenia-related genes. Proceedings of the National Academy of Sciences, 116(19):9604–9609, April 2019. URL: http://dx.doi.org/10.1073/pnas.1820754116, doi:10.1073/pnas.1820754116. This article has 214 citations.](https://doi.org/10.1073/pnas.1820754116)